
Novelzyme Bioscience Private Limited
Founded in 2017 and headquartered in Tamil Nadu, India.
Founded in 2017 and headquartered in Tamil Nadu, India.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
U24304TN2017PTC116732
116732
Private Limited Indian Non-Government Company
24 May 2017
-
-
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Patrick Kumar ![]() | Director | 24-May-2017 | Current |
Chinnaswamy Sridhar ![]() | Director | 24-May-2017 | Current |
Chandra Ramprasath ![]() | Director | 24-May-2017 | Current |
Enhance accessibility to Novelzyme Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Novelzyme Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Chinnaswamy Sridhar and Chandra Ramprasath are mutual person
Patrick Kumar is a mutual person
Patrick Kumar is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Novelzyme Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novelzyme Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novelzyme Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Patrick Antony Ashok Kumar was appointed as a Director was appointed as a Director on 24 May 2017 & has been associated with this company since 7 years 10 months .
Chinnaswamy Sridhar was appointed as a Director was appointed as a Director on 24 May 2017 & has been associated with this company since 7 years 10 months .
Chandra Sekaran Ramprasath was appointed as a Director was appointed as a Director on 24 May 2017 & has been associated with this company since 7 years 10 months .
Novelzyme Bioscience Private Limited was registered on 24 May 2017 with Roc Chennai & aged 7 years 10 months as per MCA records.
Novelzyme Bioscience Private Limited was incorporated on 24 May 2017.
The authorized share capital of Novelzyme Bioscience Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.15 M.
Currently 3 directors are associated with Novelzyme Bioscience Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Novelzyme Bioscience Private Limited is 369/1B Sunshine Villa, 10Th Street Z Block Belly Area, Anna Nagar Chennai, Tamil Nadu, India, 600040.
The corporate identification number (CIN) of Novelzyme Bioscience Private Limited is U24304TN2017PTC116732 and the company number is 116732 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.